Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added topic tags: Prostate cancer and related topics: MedlinePlus Genetics. These additions appear in the page metadata/navigation and do not modify the trial details.
    Difference
    0.2%
    Check dated 2025-10-26T20:46:52.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated revision to v3.2.0; removed a MedlinePlus Genetics topic on Prostate cancer and old revision v3.1.0.
    Difference
    5%
    Check dated 2025-10-05T10:17:26.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Page updated to v3.1.0 with new MedlinePlus Genetics content on Prostate cancer; previous v3.0.2 revision removed. No other substantive content changes identified.
    Difference
    0.5%
    Check dated 2025-09-28T03:17:35.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Updated the page from v3.0.1 to v3.0.2. Removed the 'Back to Top' element as part of the update.
    Difference
    0.3%
    Check dated 2025-09-13T17:17:26.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.3%
    Check dated 2025-09-06T14:39:19.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new pharmaceutical compounds related to cancer treatment. Notably, previous location details and specific genetics topics have been removed.
    Difference
    2%
    Check dated 2025-08-30T11:24:39.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.